0

Arrowhead Announces IND Filing To Begin Two Trials For Hepatitis B

Shares of Arrowhead Research Corp (ARWR) jumped 10% today on the news that the company has filed an IND to the FDA to begin testing two phase 2b trials using its drug ARC-520 in patients with the Hepatitis B virus.… Continue Reading

1

Shares of Bluebird Bio Surge 60% At Market Open On Positive Results Against Rare Blood Disease

Shares of Bluebird Bio (BLUE) jumped  60% on the open after it had announced that one if its drugs Lentiglobin BB305 which utilizes gene therapy was able to allow patients to become tranfusion free. Bluebird Bio is a biotechnology stock… Continue Reading

0

IsoRay’s Drug Stops Brain Cancer From Recurring In Advanced Stage Cancer patients

Yesterday December 1, 2014 Isoray (ISR) reported positive results in a brain cancer study where the patients’ recurrence of brain cancer was completely stopped . The patients were treated with Isoray’s drug known as Cesium-131 which is a titanium radioactive… Continue Reading

2

NewLink Genetics Scores Partnership With Merck For Experimental Ebola Vaccine

On Monday November 24th 2014 NewLink Genetics (NLNK) had announced that it had entered into a partnership agreement with Merck (MRK) to co-develop an experimental vaccine for Ebola known as rVSV-EBOV. Under the terms of the agreement Merck will pay… Continue Reading

0

CytRx Announces Partial Clinical Hold On Main Drug, Big Buying Opportunity For Investors

Shares of CytRx Corporation (CYTR) fell as low as 10% in the day as the company had received notice that the FDA would place a partial clinical hold on its Aldoxorubicin drug which is being used in patients with multiple… Continue Reading

0

Achillion Pharmaceuticals Continues To Impress With Hepatitis C Results In A Combination Study

Shares of Achillion Pharmaceuticals (ACHN) soared as much as 27% in yesterdays trading session after the company reported a combination study showed a 100% Sustained Viral Response — SVR — in patients with the Hepatitis C virus. The positive results… Continue Reading

0

Geron Shares Surge 25% After The Removal Of A Clinical Hold By The FDA For Imetelstat

Shares of Geron (GERN) surged as much as 25% after the company announced that the FDA has removed the full clinical hold on one of its key drug known as Imetelstat. Back in March of 2014 the FDA has placed… Continue Reading

0

Novavax Is A Great Ebola Vaccine Company To Keep An Eye On

Recently the CDC had first announced that the Ebola Virus could only be transmitted by physical contact of fluids from the other person. For awhile now many biotechnology stocks have traded higher on this premise as people feared a much… Continue Reading

0

Inovio Pharmaceuticals: The Partnerships Keep On Rolling In

Today Inovio Pharmaceuticals (INO) announced that it is collaborating with MedImmune and The University of Pennsylvania to create monoclonal antibodies — mAbs — that will be used to treat a multitude of infectious diseases. MedImmune is the research arm that… Continue Reading

0

Alnylam Keeps Making New Strides In RNAi Research

Shares of Alnylam Pharmaceuticals (ALNY) spiked as high as 18% yesterday after the company announced results from a phase 2 open-label study in patients with TTR-Amyloidosis in FAP. For starters open-label study means that Physicians and patients know that they… Continue Reading